Intracardiac masses denote anomalous growths or accumulations within the heart's chambers. These formations exhibit diverse compositions and origins, encompassing benign tumors, blood clots, and more grave conditions like cancers. Their presence can precipitate notable challenges to cardiac function, potentially impeding blood circulation and giving rise to complications such as embolism or obstruction. Advanced diagnostic methods, including echocardiography and cardiac MRI, assume a pivotal role in discerning and characterizing these masses. These techniques empower healthcare practitioners to determine the most suitable course of treatment. The management of intracardiac masses may entail medical therapies, surgical procedures, or a blend of approaches, contingent upon the nature and severity of the mass in question. A prompt identification and intervention are imperative for effectively addressing intracardiac masses and safeguarding overall cardiac health.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt